Virus-like antigen display for cancer vaccine development, what is the potential?

Research output: Contribution to journal › Letter › Research › peer-review

Standard

Virus-like antigen display for cancer vaccine development, what is the potential? / Sander, Adam F; Lollini, Pier-Luigi.

In: Expert Review of Vaccines, Vol. 17, No. 4, 2018, p. 285-288.

Research output: Contribution to journal › Letter › Research › peer-review

Harvard

Sander, AF & Lollini, P-L 2018, 'Virus-like antigen display for cancer vaccine development, what is the potential?', Expert Review of Vaccines, vol. 17, no. 4, pp. 285-288. https://doi.org/10.1080/14760584.2018.1455505

APA

Sander, A. F., & Lollini, P-L. (2018). Virus-like antigen display for cancer vaccine development, what is the potential? Expert Review of Vaccines, 17(4), 285-288. https://doi.org/10.1080/14760584.2018.1455505

Vancouver

Sander AF, Lollini P-L. Virus-like antigen display for cancer vaccine development, what is the potential? Expert Review of Vaccines. 2018;17(4):285-288. https://doi.org/10.1080/14760584.2018.1455505

Author

Sander, Adam F ; Lollini, Pier-Luigi. / Virus-like antigen display for cancer vaccine development, what is the potential?. In: Expert Review of Vaccines. 2018 ; Vol. 17, No. 4. pp. 285-288.

Bibtex

@article{a00862b2d0ea431fb7433ff2164de5e5,
title = "Virus-like antigen display for cancer vaccine development, what is the potential?",
author = "Sander, {Adam F} and Pier-Luigi Lollini",
year = "2018",
doi = "10.1080/14760584.2018.1455505",
language = "English",
volume = "17",
pages = "285--288",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
publisher = "Taylor & Francis",
number = "4",

}

RIS

TY - JOUR

T1 - Virus-like antigen display for cancer vaccine development, what is the potential?

AU - Sander, Adam F

AU - Lollini, Pier-Luigi

PY - 2018

Y1 - 2018

U2 - 10.1080/14760584.2018.1455505

DO - 10.1080/14760584.2018.1455505

M3 - Letter

C2 - 29560746

VL - 17

SP - 285

EP - 288

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 4

ER -

ID: 195776173